chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within a half hour of injection, I experienced pain in my left leg (thigh muscle mostly). Throughout the day the pain spread to my left hip and left calf. Additionally, I felt like my muscles were ?on fire? on the left side of my body. I also felt a ?tingling? in my body, fingers and toes, leg muscles, primarily on left side. (I assumed at that time that this was ?normal?.) About 11 hours after injection, I experienced extreme muscle pain all over my body, lasting for about 12 hours. (Flu-like muscle pain and the feeling that all of my muscles were on fire.) The following day, I began to feel the feeling of pins and needles everywhere but primarily on left leg, thigh and calf.  By Thursday evening (three days following injection), I felt the most severe pins and needles feeling as well as ?itching? primarily in calves and hands and feet. I was so uncomfortable and panicked, I couldn?t sleep. On Friday evening, I felt intense leg pain and ?heat? on left side in both calf and thigh muscle and couldn?t sleep. On Saturday evening and all day Sunday I had a headache which I can?t say was related but caused me great concern. Now, eight days later, most of the pins and needles feeling has subsided but the pain in my left leg (thigh muscle) is at an all time high. Extra strength Tylenol is not helping. I did have a consult with my doctor last Thursday and I called again yesterday and I?m waiting for a call back. (Last Thursday, she agreed that my symptoms were unusual and thought I might need to see a neurologist.) Additionally - my left knee has bothered me and feels like someone hit it with a bat. I?m not sure if this is joint pain?  FYI - I have no apparent swelling in legs, no numbness, no trouble breathing and no significant headache today. I never had a fever or chills. The injection site burned for a few days (mild)  but was never red.
This is a spontaneous report from a contactable consumer. A 60-year-old female patient started to receive bnt162b2 (manufacturer unspecified), lot number: EL4238, via an unspecified route of administration in the left arm, on 21Jan2021 15:00 at SINGLE DOSE for COVID-19 immunization. Medical history included arthritis. Patient's known allergies are Penicillin, Peanut and Dairy. Patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. There were no concomitant medications.  The patient's whole/entire arm was killing her; she was hurting across her shoulder blades down to fingers. Her elbow and wrist were hot and she was feeling a tremble in hand which she has never had before. She later added that her joint in elbow and shoulder was now reaching down to her arm. She couldn't even wear her watch today to her work, it felt swollen, like there was liquid in it. She also can't lift her arm, move and the pain was like going into her back. The patient was taking Aleve and Advil and "it doesn't take away all but it takes away enough that she can function." She also bought a topical ointment to help numb the area and she was wearing a pain patch on my back. The outcome of events was reported as 'not recovered'. No follow-up attempts are possible. No further information is expected. Information on the batch/lot number has been obtained.
Admitted for procedure 10/4/2021-BPH with obstructions Discharged 10/5/2021 Asymptomatic for COVID
Elevated blood glucose level of 178mg/dL after receiving the second dose of BNT162B2/ Blood sugar was extremely high; Pain in the arm; This is a spontaneous report from a contactable consumer (Patient) via medical information team.  A 72-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in Arm Left on 30Aug2021; 11:30 (at the age of 72 years) (Lot Number: FC3180) as dose 2, single for covid-19 immunization.  Medical history included, type 2 diabetes mellitus diagnosed about 15 years ago, sciatica diagnosed about 5 years ago, for which the patient goes to the chiropractor for treatment, back pain and headache. Historical vaccine included, received BNT162B2 via unspecified route of administration on 09Aug2021 (at the age of 72 years) as dose 1, single for covid-19 immunization and experienced sore arm. Concomitant medications included ZINC supplements, dabigatran etexilate mesilate (PRADAXA), lisinopril, duloxetine, carvedilol, digoxin, tramadol taken for back pain, paracetamol (TYLENOL) taken for headache and dulaglutide (TRULICITY 1.5 mini pen). It was reported, the patient had second dose on 30Aug2021 and then had pain in the arm, like she was punched in the arm, like she did with the first one. The patient had type 2 diabetes and she got her blood test every Wednesday and took her dulaglutide shot after it and blood glucose was always between 122 and 133 (she also reported her blood glucose is usually 122 and never over 125). The patient blood glucose on 01Sep2021 morning was 178mg/dL, she asked if this could be caused by the vaccine. The sore arms lasted for about a day. Treatment for the events was not reported. The outcome for the event Pain in the arm was recovering/resolving and "Elevated blood glucose level of 178mg/dL noticed on 01Sep2021 morning during the routine blood sugar checks/ Blood sugar was extremely high" was not reported.   No follow-up attempts are needed. No further information is expected.
Rash is growing on legs and arms. It has gotten progressively worst in the last 3 hours.   I have taken Benadryl, but have no relief yet.
This spontaneous report as received from a consumer refers his a 62 year old wife with none drug reactions or allergies and none pertinent medical history. At the end of October 2012, the patient was vaccinated with a dose of ZOSTAVAX, 1 injection (dose, route, lot number not reported). No other co-suspects were reported. There was no concomitant medications. It was reported that 12 hours after vaccination (at the end of October 2012), the patient broke out in a rash that started at her arms and spread across her chest, back and legs. Her rash was a red raised area with small rash like pimples, some areas had larger hive looking pastorals. The patient was in a burning pain and could not leave her bed or have anything touch her body. Their dermatologist diagnosed the rash as contact dermatitis. Unspecified ointment was given as a treatment for adverse event. No laboratory tests were performed. At the time of the report the patient's outcome was reported as not recovered. The patient sought medical attention, saw their doctor and an unspecified dermatologist. The relatedness for contact dermatitis was not reported for ZOSTAVAX. Upon internal review, contact dermatitis was determined to be disabling. Additional information is not expected.
All body rash in the form of small red dots with small blister in the center. Not itchy or any feeling. Probably 300+ of them on body.  Have remained steady for 10 days.
Pt recv vax on 8/11/98; on 8/20/98 pt exp fever x 2 days, raised/blanched/purple &red rash on legs to arms, fussy, local petechiae, runny nose &cough;tx=Advil & Elocon; dx=cutaneous lymphoid hyperplasia-follicular pattern. This is in follow-up to report(s) previously submitted on 5/21/99. Information has been received from a registered nurse concerning a 12-month-old male with a medical history of sensitive skin and aquagenic urticaria, who on 11-Aug-1998 was vaccinated SC with the first dose of MMR II in the right arm. Concomitant vaccinations that same day included the first dose of VARIVAX. On 20-Aug-1998 the patient developed a fever and a bilateral rash on his calves. On approximately 26-Aug-1998 the patient developed a rash on his arm and by 28-AUG-1998 the patient had developed a lacy raised rash on both calves. The patient was also noted as being fussy. The rash persisted through 03-OCT-1998 and the patient was then evaluated by a dermatologist. Follow-up information received from a physician indicated on 22-AUG-1998 the patient developed a fever for two days. He also developed a rash on his calves. On 28-AUG-1998 the patient developed a fever x 1 day and the rash spread to his arms and was described as raised and blanched. On 01-SEP-1998 the patient was noted as being very fussy with faint localized petechia and was treated with ADVIL. On 28-SEP-1998 a lacy, raised rash was noted on both calves and was non-tender and blanched. Therapy with ELOCON was initiated. The patient was also noted as developing a runny nose and cough x 3 days. On 03-OCT-1998 the rash was on the legs and arms and was noted as purple and red. The patient was then referred to a dermatologist. Information received from the dermatologist indicated from medical notes on 06-OCT-1998 "probable Henoch-Schonlein purpura associated with vaccination. Consider atypical erythema multiforme or even a very unusual granuloma annulare. Patient should be worked up for any organ involvement associated with Henoch-Schonlein purpura, particularly renal disease, although he is asymptomatic at present. Biopsy not performed today because of the age of the child and inability to cooperate with procedure. Suggest a trail of BENADRYL every night at bed time to see if urticarial component of this dermatitis may be reduced. Consider biopsy if dermatitis continues to progress and patient becomes symptomatic." Medical notes from 17-NOV-1998 indicated a diagnosis of cutaneous lymphoid hyperplasia, follicular pattern of biopsy. In December, 1998 the patient was noted to have recovered. No further information is available.
Nearly immediate symptoms progressing to the following symptoms within 2 minutes: Heart Rate 150's with associated weakness and shortness of breath Circum oral parysthesias Swelling sensation of lips, tip of tongue, and throat Generalized parysthesias Dysphoria
possible useful numbers????  NDC:58160-0819-12;  58160-0819-12  MFG: Glaxo Smith Kline  After a very negative reaction to my first injection in late October, I began taking "preemptive" acetominophen (2 tablets every four hours) immediately after the time of injection.  At the time of my 1st injection, I had also had 2 other injections simultaneously (one for flu and the other for TDap).  This time, on New Years Eve, my only injection was the Shingrix shot.  Within 10 hours of the injection, despite the fever/pain reducer, I began to feel feverish.  Within 12 hours I was suffering greatly.  High fever, chills, body ache, joint pain (especially my hands, thumbs, knees and hips).  I continued taking acetominophen every 4 hours, but the symptoms did not ease until January 2, 2021 at about 10AM.  I was left feeling very weak, very worn out; tired, achy, dizzy.  My reaction this time was at least as bad as my original injection.  (This was still administered at a facility, but a different one in my town.  My other prescription number administered on 10/30/20 was RX#0776924-11712.  You sent me a follow-up question asking about batch numbers, etc., and the NDC # on the 10/30 prescription is the same as it is on the 12/31 form.  I don't know how that is possible since its from 2 different stores many miles apart?)  I have honestly never felt so sick, so weak, so afraid that it was nearing the end for me, that I might actually die from this.  My breathing was shallow, labored.  I did manage to keep hydrated, in small increments, even though I felt incredibly nauseous.  My symptoms persisted from 3:00 am on 1/1/21 until 10:00 am on 1/2/21.  I would have gone to the hospital, but Covid-19 patients inundating our hospitals ruled that out.  Thankfully, I survived.
Patient reported to pharmacy with redness, warm to the touch, and slightly raised area at the site of the vaccination. She denied feeling any other symptoms. She first noticed the rash a day after the vaccine. She was recommended BENADRYL.
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 17-FEB-2016, also reported as today, an expired dose of VARIVAX (lot # K001364, exp date: 17-FEB-2016), subcutaneously (dose or anatomical location were not provided) was administered. No concomitant mediation was informed. No adverse effect was reported. No product quality issue occurred. Additional information has been requested.
tiredness; voice is scratchy; Chills; low grade temperature; slight cough; could feel lymph nodes swollen; stuffy nose off and on; felt like her body was fighting something, something was off; This is a spontaneous report from a contactable consumer (patient). A 38-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number: EL3247, patient was 37-year-old at the time of vaccination), via an unspecified route of administration, administered in Arm Left on 09Feb2021 as DOSE 2, SINGLE for to protect her and family from Covid19 and elderly compromised family, children too young for vaccine. Medical history reported as no. There were no concomitant medications. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number: EL3247, patient was 37-year-old at the time of vaccination), via intramuscular route of administration, administered in Arm Left on 21Jan2021 as DOSE 1, SINGLE for covid-19 immunisation. It was reported that patient got the Pfizer BioNTech Covid vaccine at mid-morning/late afternoon and then both her children (2 out of 3) both tested positive for Covid and she came down with symptoms. She did an over-the-counter rapid test, and it was negative, and it was suggested for her to retest in 24-36 hours. Patient weighs between 165-170 pounds. Reported that the oldest child was showing symptoms went to the withheld and took a test on Thursday evening, 29July2021 and got the positive results back on Monday, 02Aug2021. The middle child's symptoms started a couple of days after the oldest on Friday, 30July2021 and because of the weekend they went to submit a test Monday, 02Aug2021 and got those results back late last night which was also positive. She ensured the control line showed and worked properly. It suggested for her to retest in 24-36 hours. No History of previous immunization with the Pfizer vaccine considered as suspect, no additional Vaccines Administered on Same Date of the Pfizer Suspect. On 03Aug2021, the patient experienced voice is scratchy, chills, low grade temperature, slight cough, could feel lymph nodes swollen, stuffy nose off and on, felt like her body was fighting something, something was off, on 04Aug2021, the patient experienced tiredness. The patient underwent lab tests and procedures which included temperature resulted as 100.3 on 03Aug2021, temperature resulted as 100.3 and rapid Covid testing/QuickView at home OTC Covid-19 test resulted as negative on 04Aug2021. Patient received treatment for low grade temperature with Advil. Reported that after taking advil at night before bed for the temperature/slight fever and it seemed to help and next day she woke up and she didn't feel like she had a fever at all but had other events. No AE(s) require to visit emergency Room and physician office. The outcome of event (low grade temperature) was recovered on an unspecified date in 2021 and outcomes of all other events were not recovered.  Follow-Up (09Aug2021): Follow-up attempts are completed. No further information is expected.
Returned to clinic on 06/18/08, with diffuse slightly raised erythematous rash:  oval plaques & some round on abdomen, chest, back, arms and legs.  Some hypopigmented areas - look to be clearing.  "Pityriasis like", non-itching.  No treatment ordered.  Advised to re-check in 2-3 weeks.
Second Maderna shot done 08/20/2021.  By 24 hours patient began experiencing heighten nervousness.   Began having trouble sleeping.  During the next week, patient experienced increased nervousness, listlessness,  exhaustion with sleep cycle disrupted and loss of time from work due to exhaustion.   Patient averaged 3  to 5 hours per night sleep.  By the following Friday (08/27/2021) patient experienced additional severe pain lower cervical, upper thoracic spinal areas.   Patient visited Urgent Care on Monday August 30, due to alarming high blood pressure, severe pain.   Urgent care did blood work, ekg,  BP.....over 210/110 with St changes on EKG.  BP did not respond to BP meds....recommeded Emergency Room.   Clonidin
patient fainted a few minutes after getting pfizer covid vaccine. She felt better 5 minutes later, Her blood pressure was 113/69 pulse 73. Her blood pressure was 98/64, pulse 80 30 minutes after. But she felt perfectly fine then.
She had immediate pain after the procedure. Since then, she has worsening shoulder pain with immobility due to a fear of the joint being unstable.
Headache, Myalgia, Fever, neck and back pain, nasal congestion, fatigue Narrative:
Ache/pain in left shoulder; Ache/pain in collarbone; Ache/pain in neck; This is a spontaneous report from a non-contactable consumer or other non-Health Care Professional. A 52-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiry date: Unknown), dose 1 via an unspecified route of administration, administered in Arm Left on 13Feb2021 16:30 at the age of 52-years-old as DOSE 1, SINGLE for Covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. The patient was not diagnosed with Covid 19 and has not been tested for Covid-19 Since the vaccination. The patient medical history was not reported.The patient's concomitant medications were not reported. On an unspecified date the patient experienced ache/pain in left shoulder, ache/pain in collarbone, ache/pain in neck. The outcome of event was not recovered.  No follow-up attempt are possible. Information about lot/batch number cannot be obtained.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a elderly female patient who received SHINGRIX. The patient's past medical history included shingles. In May 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On an unknown date, less than a week after receiving SHINGRIX, the patient experienced injection site erythema, injection site warmth, injection site itching and injection site lump. On an unknown date, the outcome of the injection site erythema, injection site warmth and injection site itching were unknown and the outcome of the injection site lump was recovering/resolving. The reporter considered the injection site erythema, injection site warmth and injection site lump to be probably related to SHINGRIX. It was unknown if the reporter considered the injection site itching to be related to SHINGRIX. Additional details were provided as follow: The pharmacist reported the adverse event on behalf of the patient. The age at vaccination was not reported. The patient received SHINGRIX in the right arm. The reporter stated that the patient received the SHINGRIX vaccine and later that evening or the next day she felt a knot at the injection site. The reporter stated that the patient experienced an injection site reaction that he described as a circular red area around the injection site that was warm to touch and the diameter was the size of a grapefruit. The reporter stated that he told the patient to monitor the redness and aid that the patient came into the pharmacy 2 days after receiving SHINGRIX to show the injection site and told the reporter that she did not think that the area was getting larger. The reporter stated that the patient might have experienced itchiness at the injection site, but the reporter could not remember. The reporter stated that he would be following up with the patient soon.
Severe vertigo-1week Right eye  twitch-1 month Diffuse numbness and tingling remains to date
Experienced a hot; Covid arm; itchy; red spot/Rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Experienced a hot), VACCINATION COMPLICATION (Covid arm), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (red spot/Rash) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E27A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Aug-2021, the patient experienced VACCINATION SITE WARMTH (Experienced a hot), VACCINATION COMPLICATION (Covid arm), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (red spot/Rash). At the time of the report, VACCINATION SITE WARMTH (Experienced a hot), VACCINATION COMPLICATION (Covid arm), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (red spot/Rash) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications were reported. No Treatment medications were reported.
shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced DYSPNOEA (shortness of breath) (seriousness criteria hospitalization and medically significant). At the time of the report, DYSPNOEA (shortness of breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   This case was linked to MOD-2021-137907 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded
no adverse event; PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE; Information has been received from Centers for Disease Control (CDC) On 21-SEP-2023 referring to a 9-month-old male patient. The patient's concurrent conditions, concomitant therapies, historical drugs and historical conditions were not reported.  On 14-JUL-2023, the patient (at 9 month instead of at 12 months by mistake) (product administered to patient of inappropriate age) was vaccinated with pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) injection, lot #X004289, expiration date was validated as 10-DEC-2024, administered intramuscularly (strength was not provided) at Left Lower Forearm; and  measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, administered intramuscularly (lot #X005838; strength, dose, and expiry date were not provided) at right Lower Forearm; varicella virus vaccine live (oka/merck) (VARIVAX) injection, lot #W039688, expiration date was validated as 13-DEC-2024, administered intramuscularly at Left Lower Forearm(strength was not provided). All vaccines were vaccinated for prophylaxis. Patient was held for 20 min after the vaccinations were given. there was no adverse reactions to the vaccinations (no adverse event). The only issue was that they were given early for what was considered the time frame to receive these vaccinations.  Lot No. X005838 has been verified to be a valid lot number for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, expiration date not reported, but upon internal validation established as 03-JUN-2024.